Other safety alerts
|
| |
| The United States: FDA warns health care professionals not to inject patients with IV solutions from Wallcur, of San Diego |
| |
The U.S. Food and Drug Administration (FDA) is alerting health care professionals not to use Wallcur, LLC, simulated intravenous (IV) products in human or animal patients. These products are for training purposes only. FDA has become aware that some Wallcur training IV products have been distributed to health care facilities and administered to patients. There have been reports of serious adverse events associated with the use of certain of these products – i.e., Practi IV Solution Bags. Before administering IV solutions to patients, health care providers should carefully check the labels to ensure that the products are not training products, which may bear the words “for clinical simulation,” are not to be administered to patients.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/DrugSafety/ucm428431.htm
In Hong Kong, there is no registered pharmaceutical products manufactured by Wallcur, LLC.
Ends/ Wednesday, December 31, 2014
Issued at HKT 15:00
|
| |
|
